More Articles
Aria CV, a Minnesota-based medical device company, announced that its new implantable device for treating pulmonary hypertension and limiting symptoms that can lead to heart failure has been successfully implanted into a patient for…
Startup vendor FIRE1 announced it completed patient enrollment in its U.S. early feasibility study for a heart failure remote monitoring device that directly measures…
Forbes Health has published an updated list of its top 5 heart-healthy diets, with two familiar options—the Mediterranean and DASH diets—coming in at No. 1 and No. 2, respectively.
Three independent…
Inaccurate pulse oximeter readings impact Black heart failure patients and FDA plans to address this
Heart failure providers use pulse oximeter readings to guide medication management decisions, as well as to determine whether patients are candidates for heart transplants or left ventricular assist devices (LVADs). However, racially biased…
Reprieve Cardiovascular Inc. announced this week it has raised $42 million in series A financing to advance clinical trials for its automated diuretic and fluid management treatment for acute decompensated heart failure (ADHF). The company said…
Researchers have developed a new risk score that could help doctors identify which heart transplant candidates face the highest mortality risk if they do not receive a new heart. The group shared its findings in JAMA, noting…
Impulse Dynamics, a New Jersey-based medical device company focused on heart failure treatments, has raised $136 million in financing. The funds are…
Scot Pollard, who played several seasons in the NBA and competed on “Survivor,” has been admitted to the ICU at Vanderbilt University Medical Center in desperate need of a heart…
Total artificial hearts: Exploring the future of heart transplant technology with a renowned surgeon
Procyrion, a Houston-based healthcare technology company, has raised $57.7 million in Series E funding to support ongoing research into its Aortix percutaneous mechanical circulatory support (pMCS) device.
…
Researchers have used artificial intelligence to develop and validate a new risk score designed to guide the treatment of patients with acute…
Transcatheter aortic valve replacement (TAVR) is much riskier when treating patients with severe obesity than it is in patients with a…
The risk of severe maternal morbidity (SMM), defined by the Centers for Disease Control and Prevention (CDC) as “unexpected outcomes of labor and delivery that result in significant short- or long-…
Bruce Wilkoff, MD, a veteran cardiologist with Cleveland Clinic and a giant in the field of cardiovascular medicine, died Sunday, Jan. 7. He was 69 years old.
Wilkoff worked at Cleveland Clinic for…
Advanced artificial intelligence (AI) models designed to detect early signs of …
Falls, infections much more likely among Medicare patients treated at private equity-owned hospitals
Private equity firms and private equity-backed physician groups have grown increasingly influential in the world of healthcare in recent years. The trend has carried over into several specialties, including cardiology, leading to more…
Heart transplant recipients who receive a heart from a significantly older donor may experience certain side effects associated with accelerated aging, according to new research on mice models. The study, published in the American…
Abbott’s HeartMate 3 left ventricular assist device (LVAD), a heart pump approved by the…
Science, a popular journal published by the American Association for the Advancement of Science (AAAS), has announced that ongoing research into the benefits of GLP-1 agonists such as…
Treatment with dapagliflozin is associated with improved symptoms in patients with heart failure with reduced ejection fraction (HFrEF), but not patients with heart failure with preserved ejection fraction (HFpEF), according to new…